Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
Ascendis Pharma A/S (ASND) Non-Performing Assets / Total Loans data is not available.
| Income Statement Financials | |
$249.72M |
|
$-71.29M |
|
$26.13M |
|
$223.59M |
|
$236.86M |
|
$12.85M |
|
$-79.92M |
|
$-67.06M |
|
$-67.06M |
|
$-71.29M |
|
$-71.29M |
|
$-71.29M |
|
$-71.29M |
|
$12.85M |
|
$17.85M |
|
60.76M |
|
60.76M |
|
$-1.17 |
|
$-1.17 |
|
| Balance Sheet Financials | |
$1.19B |
|
$118.95M |
|
$160.10M |
|
$1.35B |
|
$1.15B |
|
$387.34M |
|
$400.16M |
|
$1.55B |
|
$-203.48M |
|
$-207.85M |
|
$-203.48M |
|
61.10M |
|
| Cash Flow Statement Financials | |
$-22.79M |
|
$-5.95M |
|
$32.51M |
|
$654.05M |
|
$630.14M |
|
$-23.91M |
|
$100.78M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.03 |
|
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
2.11 |
|
-4.67 |
|
89.54% |
|
5.15% |
|
5.15% |
|
-- |
|
-26.86% |
|
-28.55% |
|
$-28.75M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
0.07 |
|
1.45 |
|
62.03 |
|
35.04% |
|
34.30% |
|
-5.28% |
|
-38.77% |
|
$-3.33 |
|
$-0.47 |
|
$-0.38 |
|